Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Terminated

Conditions: Prostatic Neoplasm

Interventions: Diagnostic Test: Fluciclovine PET/CT using a digital PET/CT

First Posted Date: 2020-01-21

Last Posted Date: 2024-01-24

Lead Sponsor: University of Vermont

Target Recruit Count: 22

Registration Number: NCT04234399

Locations: 🇺🇸
UVM Medical Center, Burlington, Vermont, United States

Cholinergic Health After Menopause (CHAMP)

Early Phase 1

Completed

Conditions: Postmenopausal Symptoms
Aging
Alzheimer Disease

Interventions: Drug: Cholinergic antagonist

First Posted Date: 2019-10-16

Last Posted Date: 2025-04-08

Lead Sponsor: University of Vermont

Target Recruit Count: 120

Registration Number: NCT04129060

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

Prolonged Exposure Therapy for PTSD and Opioid Use Disorder

Not Applicable

Completed

Conditions: Opioid-use Disorder
Post Traumatic Stress Disorder

Interventions: Behavioral: Prolonged Exposure Therapy
Behavioral: Attendance-based monetary incentives

First Posted Date: 2019-09-26

Last Posted Date: 2025-01-09

Lead Sponsor: University of Vermont

Target Recruit Count: 52

Registration Number: NCT04104022

Locations: 🇺🇸
University of Vemont, Burlington, Vermont, United States

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: Cigarettes with varying nicotine content
Other: E-Cigarettes

First Posted Date: 2019-09-17

Last Posted Date: 2025-03-30

Lead Sponsor: University of Vermont

Target Recruit Count: 326

Registration Number: NCT04092101

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Shirley Plucinski, Burlington, Vermont, United States

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Not Applicable

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: Varying the nicotine content of cigarettes
Other: E-Cigarettes

First Posted Date: 2019-09-17

Last Posted Date: 2025-03-18

Lead Sponsor: University of Vermont

Target Recruit Count: 326

Registration Number: NCT04092387

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

Cooking as a Health Behavior in College Students

Not Applicable

Completed

Conditions: Diet, Healthy

Interventions: Behavioral: Active Cooking Classes
Behavioral: Meal Kits
Behavioral: Recipes

First Posted Date: 2019-09-10

Last Posted Date: 2021-07-08

Lead Sponsor: University of Vermont

Target Recruit Count: 53

Registration Number: NCT04084028

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Testing a Modified Family Planning Intervention for Postpartum Women in Uganda

Phase 1

Conditions: Contraceptive Usage

Interventions: Behavioral: Contraceptive management program

First Posted Date: 2019-08-28

Last Posted Date: 2019-08-28

Lead Sponsor: University of Vermont

Target Recruit Count: 20

Registration Number: NCT04068870

Locations: 🇺🇬
Nakaseke District Hospital, Nakaseke, Uganda

Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment

Not Applicable

Completed

Conditions: Acute Respiratory Failure
Encephalopathy
ARDS
Critical Illness
Sepsis

Interventions: Device: Exersides

First Posted Date: 2019-08-26

Last Posted Date: 2022-03-10

Lead Sponsor: University of Vermont

Target Recruit Count: 58

Registration Number: NCT04067622

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions

Completed

Conditions: Opioid-use Disorder
Opioid Withdrawal
Neonatal Abstinence Syndrome
Neonatal Opioid Withdrawal Syndrome

Interventions: Other: Medically-supervised withdrawal
Other: Opioid agonist treatment
Behavioral: Comprehensive clinical care

First Posted Date: 2019-08-08

Last Posted Date: 2024-02-08

Lead Sponsor: University of Vermont

Target Recruit Count: 88

Registration Number: NCT04049799

Locations: 🇺🇸
Mountain Area Health Education Center, Asheville, North Carolina, United States
🇺🇸
UNC Chapel Hill Horizons, Chapel Hill, North Carolina, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

and more 1 locations

Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women

Phase 1

Active, not recruiting

Conditions: Tobacco Use Disorder

Interventions: Other: Very low nicotine content cigarettes

First Posted Date: 2019-07-26

Last Posted Date: 2024-02-07

Lead Sponsor: University of Vermont

Target Recruit Count: 66

Registration Number: NCT04033237

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy